Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model

Autor: Capitao, Marisa, Perrin, Justine, Simon, Sylvain, Gouard, Sébastien, Chouin, Nicolas, Bruchertseifer, Frank, Morgenstern, Alfred, Rbah-Vidal, Latifa, Chérel, Michel, Scotet, Emmanuel, Labarrière, Nathalie, Guilloux, Yannick, Gaschet, Joëlle

Publikováno v: Cancers
Volume 13
Issue 6
Cancers, 2021, 13 (6), pp.1256. ⟨10.3390/cancers13061256⟩
Cancers, Vol 13, Iss 1256, p 1256 (2021)
Cancers, MDPI, 2021, 13 (6), pp.1256. ⟨10.3390/cancers13061256⟩

Simple Summary In recent years, the development of immune checkpoint inhibitors, such as anti-PD‑1 and anti-PD-L1, proved to prolong melanoma patient survival and are now used in routine clinical practice. PD-L1 also represents a potent biomarker f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::79c01da7a0c73a9e37e9191fd27ee9b9

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.